Fujifilm Irvine workforce cuts; Gates Foundation invests in Africa-made vaccines; Sharp acquires BSM
12 Oct 2023
VaccinemRNAClinical Study
Welcome to Endpoints News’ manufacturing news briefs, where we bring you essential updates on new builds, collaborations, recalls, and more.
This week we saw Fujifilm Irvine Scientific lay off employees across its facilities in California, as well as the Gates Foundation investing $40 million in vaccines for lower- and middle-income countries by leveraging Quantoom Biosciences’ mRNA tech.
We zero in on multiple builds, including eXmoor pharma’s new 65,000 square-foot cell and gene facility in Bristol, UK, as well as China-based Sino Biological launching its first facility in the US for recombinant protein production.
Preview
Source: EndPoints
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
SIGN UP
LOG IN
BECOME A PREMIUM SUBSCRIBER
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.